Ignite Creation Date:
2024-05-06 @ 8:13 PM
Last Modification Date:
2024-10-26 @ 3:23 PM
Study NCT ID:
NCT06300918
Status:
RECRUITING
Last Update Posted:
2024-03-19
First Post:
2024-02-22
Brief Title:
A Clinical Trial to Evaluate the Time Point of Anti-VEGF Pretreatment of PDR Based on Intraoperative FFA
Sponsor:
Jie Li
Organization:
Sichuan Provincial Peoples Hospital
Study Overview
Official Title:
A Randomized Controlled Clinical Trial to Evaluate the Time Point of Anti-VEGF Pretreatment of PDR Based on Intraoperative FFA
Status:
RECRUITING
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this prospective randomized controlled study is to compare the therapeutic effect of injecting anti-VEGF drugs before surgery for patients with proliferative diabetic retinopathy at different time points At present studies have confirmed that anti-VEGF drugs are effective in inhibiting fundus neovascularization in proliferative diabetic retinopathy The main question it aims to answer is which time point is better to injecting anti-VEGF drugs before surgery for patients with proliferative diabetic retinopathy
Participants will be randomly divided into three groups And time points of injecting anti-VEGF drugs before surgery for each group will be 3 days 7 days 14 days And we have a new technology that can have fluorescein fundus angiography during operation so it can reflect the condition of fundus neovascularization immediately and precisely In that case we can compare the Inhibitory effect of anti-VEGF drugs on fundus neovascularization at different time points
Participants will be randomly divided into three groups And time points of injecting anti-VEGF drugs before surgery for each group will be 3 days 7 days 14 days And we have a new technology that can have fluorescein fundus angiography during operation so it can reflect the condition of fundus neovascularization immediately and precisely In that case we can compare the Inhibitory effect of anti-VEGF drugs on fundus neovascularization at different time points
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None